# Evaluation: GigPurse v2

**Synthetic illustrative output; not a runtime evaluation or externally verified investment advice.** Report ID: `gigpurse-v2-evaluation-fixture-01`. Source: [`v2.md`](v2.md), plus GP-D001–GP-D005 in the revision record.

Source version: `v2`; SHA-256: `79ce46a0b5a107ba03d06e948945ef84736471ffab0020e1f0a78279666fc011`.

## Decision scope and coverage

**Assessment status: complete. Business verdict: Proceed with caution.** This applies only to two-week discovery capped at $600 and 16 founder-hours. It does not approve the $750,000 raise, which remains **insufficient_evidence; business verdict: null** because payment, acquisition, production feasibility, and costs have not been established.

All four axes completed for the bounded exercise. Feasibility checked budget/time sums, manual scope, recruiting dependency, and stop conditions. This is a completed review of discovery, not production-fintech readiness.

## Normalized findings

| Finding / causal issue / assumption | Severity / type | Evidence and consequence |
|---|---|---|
| GP-F008 / GP-I008 / GP-A008 | High; supported selection constraint | `v2.md#discovery-plan` and GP-D003 restrict recruitment to a prior waitlist. This limits whose behavior can be observed and blocks interpreting success as general acquisition evidence. origin=document; doc_support=supported; external_status=not_checked; confidence=high. |
| GP-F002 / GP-I002 / GP-A002 | High for raise; unresolved question | GP-D004 provides no payments. WTP remains unresolved; users' refusal is not proved. origin=user; doc_support=supported; external_status=not_checked; confidence=high about missing evidence. |
| GP-F006 / GP-I006 / GP-A006 | Medium for discovery; plausible risk | A two-week task cannot establish long-term retention. Adding a habit feature does not resolve the risk. origin=reviewer; doc_support=not_established for actual retention; external_status=not_checked; confidence=medium. |
| GP-F007 / GP-I007 / GP-A007 | Medium; unresolved question | Setup effort will be observed; results do not exist. origin=reviewer; doc_support=not_established; external_status=not_checked; confidence=medium. |

GP-F001 is corrected; GP-F003's forecast is withdrawn while acquisition remains unknown; GP-F004 is out of prototype scope; GP-F005 is a user choice. No retained Critical is supported. GP-F008 discussed by Risk and ROI is one issue, not independent corroboration.

For this bounded decision, only GP-F008 has `affects_decision=true`, `kind=risk`, `evidence_basis=document_logic`, `status=active`, and `resolution=unresolved`. Its consequence is conditional continuation: do not treat waitlist results as permission for wider acquisition. GP-F002, GP-F003, GP-F006, and GP-F007 remain tracked with `affects_decision=false` for discovery; they are evidence gaps for the separate raise. Keeping the study's purpose and these limitations explicit is essential to that distinction.

## Verdict computation

Coverage is complete and the bounded decision is assessable. Retained Critical count: **0**. GP-F008 is a High limitation material to interpreting results and proceeding beyond discovery. Zero Criticals does not automatically return Invest; this unresolved High yields **Proceed with caution**. Rule result and final verdict agree; **no override**.

Contract result: `assessment_status=complete`, `mechanical_verdict=Proceed with caution`, `verdict=Proceed with caution`, `override=null`.

Proceed within GP-D001's cap and interpretation limits. If eligible recruitment fails, stop and record it. Accepting a document does not authorize a broader acquisition campaign or production launch.

## Evidence and verification report

Internally checked: market arithmetic, same-period LTV illustration, budget/time sums, source mapping, absence of paid results. Externally checked: none. Fictional user decisions remain origin `user`, external_status `not_checked`. No API, tax, market, or competitor claim is externally verified.

## Next experiment and reassessment

This tests whether the task merits further discovery, not the original investment thesis. Collect the task/return records in v2 during two weeks after user initiation under the accepted $600/16-hour cap. Six first sessions/four return attempts are affordable exploratory targets, not prevalence estimates. Record failures and dropouts.

If observations warrant another step, ask about broader recruitment and real-payment testing, with their own budget, threshold rationale, and decision. A successful small pilot triggers reassessment; it does not automatically flip the raise to Invest. The loop waits for actual evidence. The agent writes the next revision when facts or decisions arrive; the user is never assigned a rewrite.
